EC Healthcare Opens New Multi-Service Flagship Medical Centre at Central and Advanced Imaging Centre at Taikoo
Further Expand Market Share in Medical Market
HONG KONG, Apr 04, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group's new multi-service flagship medical centre ("New Flagship Centre") located in Central and its new advanced imaging centre located in Tai Koo have commenced operations on 31 March 2022 and 1 April 2022 respectively, thus further expanding the Group's market share in the medical market.
The New Flagship Centre is located at Fung House in Central, Hong Kong Island, with seven new floors with an aggregate gross floor area of approximately 22,000 square feet. The upper five floors of the New Flagship Centre offer services including but not limited to general medical, orthopedics, ophthalmology, chiropractic, physiotherapy and pain management and service centres have commenced operations. The other two floors will be an advanced imaging centre serving as a one-stop medical imaging service hub, which is expected to commence operation in the fourth quarter of 2022.
In addition, the gross floor area of another new advanced imaging centre is located on 6/F of Cityplaza in Tai Koo, Hong Kong Island is approximately 3,400 square feet. After this expansion, the Group operates six advanced imaging centres across the New Territories, Kowloon and Hong Kong Island, thereby further improving its service network.
Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "EC Healthcare has been developing preventive and precision medicine as its core businesses. To fulfill the strong demand for medical services, the Group has established the related service centres through organic growth in an effort to further exploit business synergy among its diversified medical and healthcare businesses. The Group will remain committed to building up an enclosed healthcare ecosystem focused on satisfaction of customers in order to provide quality one-stop services to the customers and consolidate the Group's industry leadership as a one-stop comprehensive healthcare and medical service provider."
About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the MSCI Small Cap Index and the Hang Seng Composite Index.
The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre SPINE Central, New York Spine and Physiotherapy Center NYMG, health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, a comprehensive dental centre UMH DENTAL CARE, a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic SPECIALISTS CENTRAL and NEW MEDICAL CENTER, obstetrics and gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, specialists central, a paediatric center PRIME CARE, cardiology center HONG KONG INTERNATIONAL CARDIOLOGY CENTER, PathLab Medical Laboratories, a professional hair care center HAIR FOREST, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.
*According to independent research conducted by Frost and Sullivan in terms of revenue in 2019 and 2020
For further information, please contact: iPR Ogilvy Limited Callis Lau / Lorraine Luk / Charmaine Ip Tel: (852) 2136 6952 / 2169 0467 / 3920 7649 Fax: (852) 3170 6606 Email: ech@iprogilvy.com
Source: EC Healthcare Sectors: BioTech, Healthcare & Pharm
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
Japan's Telecommunications Carriers Strengthen Disaster Response by Conducting Joint Training for Shared Refueling Stations Jan 28, 2025 17:39 JST
| FDA Approves LEQEMBI (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease Jan 28, 2025 09:46 JST
| Ogier's milestone Monte win crowns TOYOTA GAZOO Racing one-two Jan 27, 2025 17:24 JST
| Anime Tokyo Station: Let's Enjoy together!! History of Anime Series "OSHI NO KO" Jan 27, 2025 13:00 JST
| hootfolio, Inc., a Provider of Causal Analysis Technology, Launches Business Development Jan 27, 2025 12:01 JST
| Sustainable Shared Transport and Fujitsu launch open platform for joint transportation and delivery in Japan, enhancing logistics efficiency across industries Jan 27, 2025 10:53 JST
| DOCOMO to Exhibit at MWC Barcelona 2025, World's Largest Connectivity Exhibition Jan 24, 2025 17:39 JST
| Hitachi Launches Food Quality Visualization Solution with Time-Temperature Sensing Ink Jan 24, 2025 12:40 JST
| Mitsubishi Heavy Industries Aero Engines and Rolls-Royce Celebrate 20 Years of Collaboration Jan 24, 2025 10:38 JST
| World's First Successful Transmission of Huge Volume Mission Data Using 1.5 micron Optical Inter-Satellite Communication Jan 24, 2025 09:19 JST
| TANAKA PRECIOUS METAL TECHNOLOGIES Develops AgSn TLP Sheet, a Sheet-type Bonding Material for Power Semiconductors Jan 23, 2025 11:00 JST
| MHI Receives Order for 3 New Series Trainsets (12 Cars) for Seibu Railway's Yamaguchi Line Jan 22, 2025 17:27 JST
| Eisai Listed as a Global 100 Most Sustainable Corporation for The Ninth Time Highest Ranked Global Pharmaceutical Company Jan 22, 2025 17:18 JST
| Mitsubishi Power Advances Thailand's Energy Development with Completion of 1,400MW Combined Cycle Hin Kong Power Plant Jan 21, 2025 16:24 JST
| DENSO Exhibits at Bharat Mobility Global Expo 2025, New Delhi Jan 20, 2025 20:26 JST
| Hitachi Acquires a Sales and Maintenance Service Company for Large Motors in the United States Jan 20, 2025 15:07 JST
| Suzuki's First BEV "e VITARA" Adopts eAxle Jan 20, 2025 13:58 JST
| Honda Presents the World Premier of BF300 Large-size Outboard Motor at the Dusseldorf Boat Show 2025 Jan 20, 2025 11:36 JST
| TOYOTA GAZOO Racing begins WRC title bid with a legendary challenge Jan 17, 2025 19:53 JST
| Mitsubishi Corporation and JOGMEC Announce Investment in eFuels provider Infinium Jan 17, 2025 14:35 JST
|
More Latest Release >>
|